Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 140,200 | 156,800 | 151,800 | 176,600 | 327,700 |
| Receivables | 368,500 | 347,900 | 325,700 | 330,200 | 360,300 |
| Inventories | 290,600 | 273,500 | 253,100 | 281,300 | 271,600 |
| Income taxes - deferred | 30,700 | 29,300 | 32,100 | 15,700 | 14,400 |
| Other current assets | 36,200 | 22,600 | 25,100 | 18,600 | 22,500 |
| TOTAL | $866,200 | $830,100 | $787,800 | $822,400 | $996,500 |
| Non-Current Assets | |||||
| PPE Net | 1,107,600 | 1,070,200 | 1,047,000 | 1,013,700 | 939,400 |
| Investments And Advances | 0 | 0 | 0 | 1,300 | 0 |
| Intangibles | 681,100 | 680,500 | 682,400 | 681,800 | 687,200 |
| Other Non-Current Assets | 161,300 | 159,500 | 163,300 | 125,100 | 125,000 |
| TOTAL | $1,950,000 | $1,910,200 | $1,892,700 | $1,821,900 | $1,751,600 |
| Total Assets | $2,816,200 | $2,740,300 | $2,680,500 | $2,644,300 | $2,748,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 300 | 300 | 100 | 200 | 400 |
| Accounts payable and accrued liabilities | 198,100 | 208,600 | 175,700 | 205,800 | 207,800 |
| Accrued Expenses | 169,800 | 164,000 | 178,400 | 169,100 | 172,000 |
| TOTAL | $374,700 | $380,700 | $368,500 | $395,800 | $451,800 |
| Non-Current Liabilities | |||||
| Long Term Debt | 716,300 | 715,600 | 716,200 | 716,300 | 715,900 |
| Other Non-Current Liabilities | 366,400 | 369,600 | 382,300 | 383,500 | 392,300 |
| TOTAL | $1,115,600 | $1,116,900 | $1,130,100 | $1,128,100 | $1,140,100 |
| Total Liabilities | $1,490,300 | $1,497,600 | $1,498,600 | $1,523,900 | $1,591,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,809 | 71,712 | 71,356 | 70,924 | 72,974 |
| Common Shares | 500 | 500 | 1,000 | 500 | 500 |
| Retained earnings | 1,693,400 | 1,624,300 | 1,572,800 | 1,517,900 | 1,478,700 |
| Other shareholders' equity | 98,500 | 89,100 | 95,700 | 94,100 | 70,900 |
| TOTAL | $1,325,900 | $1,242,700 | $1,181,900 | $1,120,400 | $1,156,200 |
| Total Liabilities And Equity | $2,816,200 | $2,740,300 | $2,680,500 | $2,644,300 | $2,748,100 |